Ronald A. Ahrens

Part of Ecolab, Inc., Alcide Corp. is a private company that develops and markets biocidal products. The company is based in Redmond, WA. The CEO of the company is Joseph A. Sasenick. Alcide was acquired by Ecolab, Inc. on July 30, 2004 for $56.27 million.

St. Ives Laboratories, Inc. manufactures and markets personal care products. It is a world-wide line of botanically-based Swiss Formula skin care and hair care products. The company was founded in 1955 and is headquartered in Chatsworth, CA.

Closure Medical Corp. designs, develops and manufactures biomaterial-based medical adhesive products such as family of DERMABOND Topical Skin Adhesive products to meet topical skin adhesive needs of physicians. It was founded by F. William Schmidt in 1990 and is located in Raleigh, NC

VIASYS Healthcare Inc. develops, manufactures, and markets medical and surgical devices and products. It offers products focused on respiratory care, neuroscience, and critical care medicine. The company is headquartered in Conshohocken, PA

CardioNet LLC provides cardiac monitoring services. It operates its business through two segments: Patient Service and Product Business. The Patient Service segment focuses on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders, through its core mobile cardiac outpatient telemetry, event and Holter services. The Product Business segment focuses on the development, manufacturing, testing and marketing of medical devices and related software to medical companies, clinics and hospitals. The company was founded by James M. Sweeney in 1999 and is headquartered in Conshohocken, PA.

BioTelemetry, Inc. provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing and centralized core laboratory services for clinical research. The firm also develops proprietary integrated patient management platform that incorporates wireless data transmission network. It operates through the following segments: Healthcare, and Research. The Healthcare segment is focused on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Research segment is engaged in central core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials. The company was founded on April 22, 2013 and is headquartered in Malvern, PA.

Part of Merck KGaA, Merck Consumer Health Holding GmbH distributes over the counter drugs. The private company is based in Darmstadt, Germany. The German company was founded in 2001. Uta Kemmerich-Keil has been the CEO of the company since 2014.